These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 12769750)

  • 1. Cytokine and anti-cytokine therapies for inflammatory bowel disease.
    Ogata H; Hibi T
    Curr Pharm Des; 2003; 9(14):1107-13. PubMed ID: 12769750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
    Hibi T; Inoue N; Ogata H; Naganuma M
    J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules.
    Nakamura K; Honda K; Mizutani T; Akiho H; Harada N
    World J Gastroenterol; 2006 Aug; 12(29):4628-35. PubMed ID: 16937430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunopathogenesis of inflammatory bowel diseases].
    Neurath MF; Schürmann G
    Chirurg; 2000 Jan; 71(1):30-40. PubMed ID: 10662999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental immunomodulatory therapy of inflammatory bowel disease.
    Schreiber S
    Neth J Med; 1998 Dec; 53(6):S24-31. PubMed ID: 9883011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis.
    Siegmund B; Zeitz M
    Rocz Akad Med Bialymst; 2004; 49():22-30. PubMed ID: 15631310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy of inflammatory bowel diseases].
    Wichan P; Chojnacki J; Wojtuń S
    Pol Merkur Lekarski; 2004; 17 Suppl 1():40-3. PubMed ID: 15603345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in the treatment of inflammatory bowel disease.
    Mutlu EA; Farhadi A; Keshavarzian A
    Expert Opin Investig Drugs; 2002 Mar; 11(3):365-85. PubMed ID: 11866666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulator therapy in inflammatory bowel disease.
    Choi PM; Targan SR
    Dig Dis Sci; 1994 Sep; 39(9):1885-92. PubMed ID: 7521821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine blockade in inflammatory bowel diseases.
    Perrier C; Rutgeerts P
    Immunotherapy; 2011 Nov; 3(11):1341-52. PubMed ID: 22053885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Emerging drugs in the treatment of inflammatory bowel disease: beyond anti-TNF-α].
    Kim KO; Jang BI
    Korean J Gastroenterol; 2011 Nov; 58(5):235-44. PubMed ID: 22113039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in biological therapy for inflammatory bowel disease.
    Kurtovic J; Segal I
    Trop Gastroenterol; 2004; 25(1):9-14. PubMed ID: 15303463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New cytokine therapeutics for inflammatory bowel disease.
    Stokkers PC; Hommes DW
    Cytokine; 2004 Nov 21-Dec 7; 28(4-5):167-73. PubMed ID: 15588691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease.
    Holleran G; Lopetuso L; Petito V; Graziani C; Ianiro G; McNamara D; Gasbarrini A; Scaldaferri F
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28934123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Position statement: immunomodulator therapy for inflammatory Bowel disease.
    Lavy A; Chowers Y; Odes HS; Eliakim R;
    Isr Med Assoc J; 2003 Mar; 5(3):164-9. PubMed ID: 12725133
    [No Abstract]   [Full Text] [Related]  

  • 18. Transcending conventional therapies: the role of biologic and other novel therapies.
    Sandborn WJ
    Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S9-16. PubMed ID: 11380043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical therapy of IBD in 2009.
    Harris A; Feller ER; Shah SA
    Med Health R I; 2009 Mar; 92(3):78-81. PubMed ID: 19385382
    [No Abstract]   [Full Text] [Related]  

  • 20. What's the next best cytokine target in IBD?
    MacDonald TT; Biancheri P; Sarra M; Monteleone G
    Inflamm Bowel Dis; 2012 Nov; 18(11):2180-9. PubMed ID: 22508526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.